XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Total
Class A voting common stock
Class B voting common stock
Common stock
Class A voting common stock
Common stock
Class B voting common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2022       23,379,000 1,965,170      
Beginning balance at Dec. 31, 2022 $ 272,177     $ 23 $ 2 $ 364,913 $ (44,214) $ (48,547)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercises of vested stock options (in shares)       22,975        
Exercises of vested stock options 155         155    
Vesting of restricted stock units (in shares)       171,950        
Vesting of restricted stock units 1     $ 1        
Equity awards withheld for tax liability (in shares)       (43,325)        
Equity awards withheld for tax liability (903)         (903)    
Unrealized loss on marketable securities 72           72  
Foreign currency translation 7,647           7,647  
Stock-based compensation 6,649         6,649    
Net income (loss) 3,611             3,611
Ending balance (in shares) at Mar. 31, 2023       23,530,600 1,965,170      
Ending balance at Mar. 31, 2023 289,409     $ 24 $ 2 370,814 (36,495) (44,936)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercises of vested stock options (in shares)       38,374        
Exercises of vested stock options 259         259    
Vesting of restricted stock units (in shares)       58,084        
Equity awards withheld for tax liability (in shares)       (2,289)        
Equity awards withheld for tax liability (30)         (30)    
Unrealized loss on marketable securities 54           54  
Foreign currency translation 234           234  
Stock-based compensation 5,866         5,866    
Net income (loss) (3,890)             (3,890)
Ending balance (in shares) at Jun. 30, 2023       23,624,769 1,965,170      
Ending balance at Jun. 30, 2023 291,902     $ 24 $ 2 376,909 (36,207) (48,826)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Vesting of restricted stock units (in shares)       51,132        
Equity awards withheld for tax liability (in shares)       (242)        
Equity awards withheld for tax liability (3)         (3)    
Conversion of Class B voting common stock to Class A voting common stock (in shares)       7,142 (7,142)      
Unrealized loss on marketable securities (129)           (129)  
Foreign currency translation (12,760)           (12,760)  
Stock-based compensation 6,107         6,107    
Net income (loss) (5,130)             (5,130)
Ending balance (in shares) at Sep. 30, 2023       23,682,801 1,958,028      
Ending balance at Sep. 30, 2023 279,987     $ 24 $ 2 383,013 (49,096) (53,956)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Vesting of restricted stock units (in shares)       523,796        
Equity awards withheld for tax liability (in shares)       (457)        
Equity awards withheld for tax liability (5)         (5)    
Unrealized loss on marketable securities (245)           (245)  
Foreign currency translation 20,577           20,577  
Unrealized (loss) gain on employee benefit plan, net (30)           (30)  
Stock-based compensation 8,040         8,040    
Net income (loss) (10,934)             (10,934)
Ending balance (in shares) at Dec. 31, 2023   24,206,140 1,958,028 24,206,140 1,958,028      
Ending balance at Dec. 31, 2023 $ 297,390     $ 24 $ 2 391,048 (28,794) (64,890)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercises of vested stock options (in shares) 10,849     10,849        
Exercises of vested stock options $ 103         103    
Vesting of restricted stock units (in shares)       920,435        
Vesting of restricted stock units 1     $ 1        
Equity awards withheld for tax liability (in shares)       (116,747)        
Equity awards withheld for tax liability (2,267)         (2,267)    
Unrealized loss on marketable securities 9           9  
Foreign currency translation (9,340)           (9,340)  
Stock-based compensation 21,536         21,536    
Net income (loss) (9,233)             (9,233)
Ending balance (in shares) at Mar. 31, 2024   25,020,677 1,958,028 25,020,677 1,958,028      
Ending balance at Mar. 31, 2024 $ 298,199     $ 25 $ 2 $ 410,420 $ (38,125) $ (74,123)